• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基因型正常表型肥厚型心肌病的延迟钆增强心血管磁共振成像

Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype.

作者信息

Strijack Bradford, Ariyarajah Vignendra, Soni Reeni, Jassal Davinder S, Greenberg Cheryl R, McGregor Robert, Morris Andrew

机构信息

Department of Medicine, St. Boniface General Hospital, University of Manitoba, Winnipeg, Manitoba, Canada.

出版信息

J Cardiovasc Magn Reson. 2008 Dec 16;10(1):58. doi: 10.1186/1532-429X-10-58.

DOI:10.1186/1532-429X-10-58
PMID:19087273
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2633334/
Abstract

A 35 year-old asymptomatic Caucasian female with a family history of hypertrophic cardiomyopathy (HCM) was referred for cardiologic evaluation. The electrocardiogram and transthoracic echocardiogram were normal. Cardiovascular magnetic resonance (CMR) was performed for further assessment of myocardial function and presence of myocardial scar. CMR showed normal left ventricular systolic size, measurements and function. However, there was extensive, diffuse late gadolinium enhancement (LGE) throughout the left ventricle. This finding was consistent with extensive myocardial scarring and was highly suggestive of advanced, non-ischemic cardiomyopathy. Genotyping showed a heterozygous mis-sense mutation (275G>A) in the cardiac troponin T (TNNT2) gene, which is causally associated with HCM. There have been no previous reports of such extensive, atypical pattern of myocardial scarring despite an otherwise structurally and functionally normal left ventricle in an asymptomatic individual with HCM. This finding has important implications for phenotype screening in HCM.

摘要

一名35岁无症状的白种女性,有肥厚型心肌病(HCM)家族史,前来接受心脏科评估。心电图和经胸超声心动图均正常。进行了心血管磁共振成像(CMR)以进一步评估心肌功能和心肌瘢痕情况。CMR显示左心室收缩大小、测量值及功能均正常。然而,整个左心室存在广泛、弥漫性晚期钆增强(LGE)。这一发现与广泛心肌瘢痕形成一致,高度提示晚期非缺血性心肌病。基因分型显示心肌肌钙蛋白T(TNNT2)基因存在杂合错义突变(275G>A),该突变与HCM存在因果关系。此前尚无关于无症状HCM个体左心室结构和功能在其他方面正常但却出现如此广泛、非典型心肌瘢痕模式的报道。这一发现对HCM的表型筛查具有重要意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd1b/2633334/08767b7acafe/1532-429X-10-58-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd1b/2633334/fcdb8425e72e/1532-429X-10-58-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd1b/2633334/08767b7acafe/1532-429X-10-58-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd1b/2633334/fcdb8425e72e/1532-429X-10-58-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bd1b/2633334/08767b7acafe/1532-429X-10-58-2.jpg

相似文献

1
Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype.基因型正常表型肥厚型心肌病的延迟钆增强心血管磁共振成像
J Cardiovasc Magn Reson. 2008 Dec 16;10(1):58. doi: 10.1186/1532-429X-10-58.
2
Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.心血管磁共振在肥厚型心肌病中的临床应用。
J Cardiovasc Magn Reson. 2012 Feb 1;14(1):13. doi: 10.1186/1532-429X-14-13.
3
Myocardial perfusion reserve quantified by cardiac magnetic resonance imaging is associated with late gadolinium enhancement in hypertrophic cardiomyopathy.通过心脏磁共振成像定量的心肌灌注储备与肥厚型心肌病的延迟钆增强相关。
Heart Vessels. 2018 May;33(5):513-520. doi: 10.1007/s00380-017-1088-y. Epub 2017 Nov 22.
4
Distribution of Hypertrophy and Late Gadolinium Enhancement in Children and Adolescents with Hypertrophic Cardiomyopathy.肥厚型心肌病患儿及青少年中肥厚与延迟钆增强的分布情况
Congenit Heart Dis. 2015 Nov-Dec;10(6):E258-67. doi: 10.1111/chd.12286. Epub 2015 Jul 20.
5
CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.肥厚型心肌病合并心房颤动患者的心脏磁共振成像结果
J Cardiovasc Magn Reson. 2009 Sep 9;11(1):34. doi: 10.1186/1532-429X-11-34.
6
Diffuse myocardial fibrosis in hypertrophic cardiomyopathy can be identified by cardiovascular magnetic resonance, and is associated with left ventricular diastolic dysfunction.肥厚型心肌病中的弥漫性心肌纤维化可以通过心血管磁共振成像来识别,并且与左心室舒张功能障碍有关。
J Cardiovasc Magn Reson. 2012 Oct 29;14(1):76. doi: 10.1186/1532-429X-14-76.
7
CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy.基因型阳性-表型阴性肥厚型心肌病的钆增强磁共振成像
JACC Cardiovasc Imaging. 2012 Jan;5(1):119-22. doi: 10.1016/j.jcmg.2011.08.020.
8
Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.用于检测小儿肥厚型心肌病中心肌纤维化的新型心脏磁共振特征追踪(CMR-FT)分析
Pediatr Cardiol. 2016 Apr;37(4):663-73. doi: 10.1007/s00246-015-1329-8. Epub 2016 Jan 30.
9
Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers.肥厚型心肌病突变携带者的心肌灌注缺陷。
J Am Heart Assoc. 2021 Aug 3;10(15):e020227. doi: 10.1161/JAHA.120.020227. Epub 2021 Jul 27.
10
The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.心血管磁共振成像在肥厚型心肌病中的现行和新兴作用。
J Cardiovasc Transl Res. 2009 Dec;2(4):415-25. doi: 10.1007/s12265-009-9136-3. Epub 2009 Nov 7.

引用本文的文献

1
Tale of two hearts: a TNNT2 hypertrophic cardiomyopathy case report.两颗心脏的故事:一例TNNT2肥厚型心肌病病例报告
Front Cardiovasc Med. 2023 Apr 27;10:1167256. doi: 10.3389/fcvm.2023.1167256. eCollection 2023.
2
Biatrial performance in children with hypertrophic cardiomyopathy: CMR study.肥厚型心肌病患儿的双心房功能:CMR 研究。
Eur Radiol. 2018 Dec;28(12):5148-5159. doi: 10.1007/s00330-018-5519-7. Epub 2018 Jun 7.
3
Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.

本文引用的文献

1
Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.肥厚型心肌病中心律失常的发生情况及频率与心血管磁共振延迟强化的关系
J Am Coll Cardiol. 2008 Apr 8;51(14):1369-74. doi: 10.1016/j.jacc.2007.11.071.
2
Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.肥厚型心肌病的MRI延迟强化
Magn Reson Imaging. 2004 Feb;22(2):155-61. doi: 10.1016/j.mri.2003.08.009.
3
Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T.
肥厚型心肌病患儿和青少年中晚期钆增强的发生率和进展情况。
Circulation. 2018 Aug 21;138(8):782-792. doi: 10.1161/CIRCULATIONAHA.117.032966.
4
Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.肥厚型心肌病肌节突变携带者无左心室肥厚时超声心动图与心脏磁共振成像的比较
Circ Cardiovasc Genet. 2013 Jun;6(3):230-7. doi: 10.1161/CIRCGENETICS.113.000037. Epub 2013 May 20.
5
[Clinical indications for the use of cardiac MRI. By the SIRM Study Group on Cardiac Imaging].[心脏磁共振成像的临床应用指征。由心脏成像SIRM研究小组撰写]
Radiol Med. 2013 Aug;118(5):752-98. doi: 10.1007/s11547-012-0899-2. Epub 2012 Nov 26.
6
Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.心血管磁共振在肥厚型心肌病中的临床应用。
J Cardiovasc Magn Reson. 2012 Feb 1;14(1):13. doi: 10.1186/1532-429X-14-13.
7
Cardiac MRI assessed left ventricular hypertrophy in differentiating hypertensive heart disease from hypertrophic cardiomyopathy attributable to a sarcomeric gene mutation.心脏磁共振成像评估左心室肥厚在区分高血压性心脏病与致心肌病变基因突变的肥厚型心肌病。
Eur Radiol. 2011 Jul;21(7):1383-9. doi: 10.1007/s00330-011-2065-y. Epub 2011 Jan 28.
8
Hypertrophic cardiomyopathy: preclinical and early phenotype.肥厚型心肌病:临床前和早期表型。
J Cardiovasc Transl Res. 2009 Dec;2(4):462-70. doi: 10.1007/s12265-009-9124-7. Epub 2009 Sep 26.
9
The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.心血管磁共振成像在肥厚型心肌病中的现行和新兴作用。
J Cardiovasc Transl Res. 2009 Dec;2(4):415-25. doi: 10.1007/s12265-009-9136-3. Epub 2009 Nov 7.
10
Review of Journal of Cardiovascular Magnetic Resonance 2009.《心血管磁共振杂志》2009 年回顾
J Cardiovasc Magn Reson. 2010 Mar 19;12(1):15. doi: 10.1186/1532-429X-12-15.
携带心肌肌钙蛋白T R92Q突变的小鼠心脏能量代谢降低。
J Clin Invest. 2003 Sep;112(5):768-75. doi: 10.1172/JCI15967.
4
Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance.钆增强心血管磁共振在肥厚型心肌病临床风险评估中的应用
J Am Coll Cardiol. 2003 May 7;41(9):1561-7. doi: 10.1016/s0735-1097(03)00189-x.
5
Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.α-原肌球蛋白和心肌肌钙蛋白T突变导致家族性肥厚型心肌病:一种肌节疾病。
Cell. 1994 Jun 3;77(5):701-12. doi: 10.1016/0092-8674(94)90054-x.